Mai-Britt Zocca

Insider Reports History

Location
1209 Orange Street, Wilmington, DE
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mai-Britt Zocca:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IO Biotech, Inc. Chief Executive Officer, Director Common Stock 49.9K $40.4K $0.81 Dec 23, 2024 Direct
IO Biotech, Inc. Chief Executive Officer, Director Common Stock 26.6K $21.5K $0.81 Dec 23, 2024 Zocca Consulting ApS
IO Biotech, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 580K Apr 2, 2025 Direct

Insider Reports Filed by Mai-Britt Zocca

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IOBT IO Biotech, Inc. Apr 2, 2025 1 $0 4 Apr 4, 2025 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Dec 23, 2024 1 $10.1K 4 Dec 23, 2024 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Mar 15, 2024 1 $0 4 Mar 18, 2024 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Aug 9, 2023 2 $75K 4 Aug 9, 2023 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Mar 20, 2023 1 $0 4 Mar 22, 2023 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Nov 9, 2021 2 $0 4 Nov 12, 2021 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Nov 4, 2021 1 $0 4 Nov 8, 2021 Chief Executive Officer, Director
IOBT IO Biotech, Inc. Nov 4, 2021 0 $0 3 Nov 4, 2021 Chief Executive Officer, Director